Latham & Watkins has advised a club of direct lenders in relation to the approximately €700 million financing in connection with the co-investment of Ardian and NB Renaissance in Neopharmed Gentili S.p.A., a leading pharmaceutical company operating in the Italian market.
Latham previously advised the lenders on Ardian’s initial investment in Neopharmed Gentili in November 2018.
The Latham team was led by Milan partners Marcello Bragliani, Antongiulio Scialpi, and Jeff Lawlis, and London partner Fergus O’Domhnaill; with Milan associates Davide Camasi and Pasquale Spiezio; London associates Julie Van der Meersche, Chloe Gontier, and Philip Rigley; and Madrid associate Blanca Vazquez de Castro.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
